We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

170 hedge funds and large institutions have $300M invested in Antares Pharma, Inc. in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 70 increasing their positions, 42 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 42

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 19

3% less call options, than puts

Call options by funds: $461K | Put options by funds: $477K

3% less funds holding

Funds holding: 175 → 170 (-5)

16% less capital invested

Capital invested by funds: $356M → $300M (-$56.3M)

Holders
170
Holders Change
-5
Holders Change %
-2.86%
% of All Funds
2.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
70
Reduced
42
Closed
19
Calls
$461K
Puts
$477K
Net Calls
-$16K
Net Calls Change
+$58K

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$2.22M
2
RCMNY
Rubric Capital Management (New York)
New York
+$2.02M
3
TAM
Tocqueville Asset Management
New York
+$1.74M
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$1.41M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.4M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.18M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$3.07M
3
Morgan Stanley
Morgan Stanley
New York
-$2.38M
4
BAS
Brown Advisory Securities
Maryland
-$1.2M
5
Deutsche Bank
Deutsche Bank
Germany
-$955K
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
126
Calton & Associates
Florida
$78K – – –
Prudential Financial
127
Prudential Financial
New Jersey
$72K -$101K -24,895 -56%
MSFS
128
Main Street Financial Solutions
Pennsylvania
$69K – – –
EAM
129
Eagle Asset Management
Florida
$62K +$23.6K +5,845 +52%
Allianz Asset Management
130
Allianz Asset Management
Germany
$61K +$5.58K +1,380 +9%
WS
131
Wedbush Securities
California
$60K – – –
Envestnet Asset Management
132
Envestnet Asset Management
Illinois
$59K +$15.2K +3,761 +30%
PA
133
Profund Advisors
Maryland
$57K -$2.63K -650 -4%
AIP
134
Ameritas Investment Partners
Nebraska
$52K – – –
HSBC Holdings
135
HSBC Holdings
United Kingdom
$52K +$57.2K +14,146 New
MCM
136
MAI Capital Management
Ohio
$51K -$54.2K -13,400 -49%
1W
137
1776 Wealth
Georgia
$51K – – –
AF
138
Arrow Financial
New York
$51K – – –
BTWM
139
Baker Tilly Wealth Management
Wisconsin
$50K +$55.8K +13,809 New
CA
140
Capital Advantage
California
$47K – – –
WG
141
Winton Group
United Kingdom
$46K +$50.6K +12,517 New
TCM
142
Traynor Capital Management
Pennsylvania
$43K +$48.5K +12,000 New
FFA
143
Founders Financial Alliance
North Carolina
$42K – – –
KAS
144
Kestra Advisory Services
Texas
$41K – – –
Zurich Cantonal Bank
145
Zurich Cantonal Bank
Switzerland
$41K – – –
PAMS
146
Pictet Asset Management (Switzerland)
Switzerland
$41K +$45.7K +11,300 New
Canada Life
147
Canada Life
Manitoba, Canada
$38K – – –
KPW
148
Kore Private Wealth
New York
$37K – – –
BCV
149
Banque Cantonale Vaudoise
Switzerland
$36K – – –
Chevy Chase Trust
150
Chevy Chase Trust
Maryland
$36K – – –
4 5
6
7 8

ATRS Hedge Fund Activity: Q3 2021 in Review

170 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q3 2021, worth a combined $300M — down 16% from $356M a quarter earlier.

Fund positioning in ATRS was balanced in Q3 2021: 19 funds opened new positions, 19 closed out, 70 added to existing stakes and 42 trimmed.

The largest buyer was Magnetar Financial, adding an estimated $2.22M. The largest seller was Fidelity Investments, cutting an estimated $8.18M.

  • 170 institutional investors held Antares Pharma, Inc. (ATRS) as of Q3 2021, down from 175 in Q2 2021.
  • Funds reported $300M of Antares Pharma, Inc. stock for Q3 2021, down 16% quarter-over-quarter.
  • 19 funds opened new Antares Pharma, Inc. positions in Q3 2021 and 19 closed out, a net change of 0 holders.
  • The largest Antares Pharma, Inc. buyer in Q3 2021 was Magnetar Financial, an estimated $2.22M added.
  • The largest Antares Pharma, Inc. seller in Q3 2021 was Fidelity Investments, an estimated $8.18M sold.

Based on aggregated 13F filings for Q3 2021.